UroGen Pharma Ltd.
URGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001668243
In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in UroGen Pharma Ltd. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 161
- +12 vs. Q2 2025
- Shares held
- 44.0M
- +4.20M (+10.6%) vs. Q2 2025
- Total value
- $878.6M
- +$333.7M (+61.2%) vs. Q2 2025
- New holders
- 34
- 48 more added
- Sold out
- 22
- 46 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 190 | $1.56B |
| Q1 2026 | 173 | $835.2M |
| Q4 2025 | 167 | $1.02B |
| Q3 2025 | 161 | $878.6M |
| Q2 2025 | 150 | $545.2M |
| Q1 2025 | 140 | $460.6M |
| Q4 2024 | 138 | $386.3M |
| Q3 2024 | 128 | $445.7M |
| Q2 2024 | 115 | $641.4M |
| Q1 2024 | 112 | $407.4M |
| Q4 2023 | 105 | $321.2M |
| Q3 2023 | 101 | $248.3M |
| Q2 2023 | 85 | $137.8M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 64 | $115.4M |
| Q3 2022 | 60 | $110.8M |
| Q2 2022 | 65 | $109.2M |
| Q1 2022 | 84 | $123.9M |
| Q4 2021 | 78 | $140.4M |
| Q3 2021 | 93 | $236.9M |
| Q2 2021 | 82 | $213.7M |
| Q1 2021 | 89 | $278.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Voya Investment Management LLC | 83,611 | $1.67M | 0.00% | +23,297+38.6% | Added |
| Oak Ridge Investments LLC | 87,507 | $1.75M | 0.11% | +16,937+24.0% | Added |
| Superstring Capital Management LP | 87,912 | $1.75M | 1.73% | 00.0% | Unchanged |
| Verition Fund Management LLC | 89,028 | $1.78M | 0.01% | +89,028 | New |
| Diadema Partners LP | 90,000 | $1.80M | 1.25% | −60,000−40.0% | Reduced |
| Charles Schwab Investment Management Inc | 91,059 | $1.82M | 0.00% | −1,839−2.0% | Reduced |
| Bank of New York Mellon Corp | 95,353 | $1.90M | 0.00% | +1,923+2.1% | Added |
| Jump Financial, LLC | 103,866 | $2.07M | 0.03% | +103,866 | New |
| Bank of America Corp | 108,454 | $2.16M | 0.00% | −156,663−59.1% | Reduced |
| Two Sigma Advisers, LP | 111,600 | $2.23M | 0.00% | +111,600 | New |
| Trexquant Investment LP | 116,436 | $2.32M | 0.02% | +116,436 | New |
| Wellington Management Group LLP | 125,298 | $2.50M | 0.00% | −32,754−20.7% | Reduced |
| Wells Fargo & Company | 125,969 | $2.51M | 0.00% | +2,610+2.1% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 126,720 | $2.53M | 0.02% | −39,374−23.7% | Reduced |
| HRT Financial LP | 133,674 | $2.67M | 0.01% | +29,448+28.3% | Added |
| MPM Oncology Impact Management LP | 135,000 | $2.69M | 0.44% | +135,000 | New |
| Susquehanna International Group, LLP | 147,225 | $2.94M | 0.00% | −337,598−69.6% | Reduced |
| Deutsche Bank AG | 162,259 | $3.24M | 0.00% | +137,651+559.4% | Added |
| UBS Group AG | 180,460 | $3.60M | 0.00% | −128,067−41.5% | Reduced |
| Panagora Asset Management Inc | 184,382 | $3.68M | 0.01% | −77,403−29.6% | Reduced |
| Walleye Capital LLC | 190,452 | $3.80M | 0.03% | −155,710−45.0% | Reduced |
| Privium Fund Management B.V. | 196,622 | $3.92M | 0.71% | +89,000+82.7% | Added |
| AQR Capital Management LLC | 204,191 | $4.07M | 0.00% | −27,383−11.8% | Reduced |
| Rice Hall James & Associates, LLC | 259,143 | $5.17M | 0.28% | −28,731−10.0% | Reduced |
| Northern Trust Corp | 261,401 | $5.21M | 0.00% | −6,317−2.4% | Reduced |
| Renaissance Technologies LLC | 275,100 | $5.49M | 0.01% | +236,900+620.2% | Added |
| Atom Investors LP | 291,962 | $5.82M | 0.44% | −25,634−8.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 297,851 | $5.94M | 0.04% | +79,351+36.3% | Added |
| Vanguard Group Inc | 303,785 | $6.06M | 0.00% | +48,814+19.1% | Added |
| Woodline Partners LP | 306,371 | $6.11M | 0.03% | −353−0.1% | Reduced |
| BNP Paribas Arbitrage, SA | 308,328 | $6.15M | 0.00% | +236,407+328.7% | Added |
| Jane Street Group, LLC | 328,419 | $6.55M | 0.01% | +181,139+123.0% | Added |
| Kynam Capital Management, LP | 282,412 | $6.94M | 0.52% | −374,161−57.0% | Reduced |
| Price T Rowe Associates Inc | 356,615 | $7.12M | 0.00% | −4,826−1.3% | Reduced |
| Two Sigma Investments, LP | 386,203 | $7.70M | 0.01% | +196,791+103.9% | Added |
| Parkman Healthcare Partners LLC | 402,595 | $8.03M | 0.88% | +225,893+127.8% | Added |
| Goldman Sachs Group Inc | 424,916 | $8.48M | 0.00% | +134,339+46.2% | Added |
| Geode Capital Management, LLC | 471,229 | $9.40M | 0.00% | +503+0.1% | Added |
| Nuveen, LLC | 507,531 | $10.1M | 0.00% | +424,385+510.4% | Added |
| JPMorgan Chase & Co | 534,545 | $10.7M | 0.00% | +144,181+36.9% | Added |
| Boxer Capital Management, LLC | 575,000 | $11.5M | 3.66% | 00.0% | Unchanged |
| Citadel Advisors LLC | 602,277 | $12.0M | 0.01% | +59,081+10.9% | Added |
| Soleus Capital Management, L.P. | 679,000 | $13.5M | 0.72% | −1,506,000−68.9% | Reduced |
| Voloridge Investment Management, LLC | 687,475 | $13.7M | 0.05% | +687,475 | New |
| OrbiMed Advisors LLC | 689,000 | $13.7M | 0.33% | +210,600+44.0% | Added |
| TCG Crossover Management, LLC | 717,347 | $14.3M | 0.70% | +717,347 | New |
| Migdal Insurance & Financial Holdings Ltd. | 770,909 | $15.4M | 0.17% | 00.0% | Unchanged |
| State Street Corp | 819,446 | $16.3M | 0.00% | +11,808+1.5% | Added |
| D. E. Shaw & Co., Inc. | 888,933 | $17.7M | 0.01% | +861,501+3,140.5% | Added |
| Tang Capital Management LLC | 1,000,000 | $19.9M | 0.77% | 00.0% | Unchanged |
| Menora Mivtachim Holdings Ltd. | 1,152,531 | $23.0M | 0.12% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 1,157,383 | $23.1M | 0.08% | +8,302+0.7% | Added |
| Acorn Capital Advisors, LLC | 1,259,749 | $25.1M | 12.76% | 00.0% | Unchanged |
| Millennium Management LLC | 1,468,737 | $29.3M | 0.02% | +874,706+147.2% | Added |
| Silverarc Capital Management, LLC | 1,577,283 | $31.5M | 4.56% | −445,199−22.0% | Reduced |
| Jefferies Financial Group Inc. | 2,199,652 | $43.9M | 0.40% | 00.0% | Unchanged |
| Morgan Stanley | 2,528,446 | $50.4M | 0.00% | +49,976+2.0% | Added |
| BlackRock, Inc. | 2,581,286 | $51.5M | 0.00% | +176,045+7.3% | Added |
| Toronto Dominion Bank | 3,190,510 | $63.7M | 0.12% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 4,216,084 | $84.1M | 2.49% | +4,216,084 | New |
| RTW Investments, LP | 4,543,895 | $90.7M | 1.12% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −830,000−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −542,366−100.0% | Sold out |
| Wildcat Capital Management, LLC | 0 | $0 | 0.00% | −495,606−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −218,837−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −185,030−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −168,779−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −94,309−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −34,004−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −26,166−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −24,839−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −19,379−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −16,747−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −16,503−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −11,843−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −11,501−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −6,703−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,017−100.0% | Sold out |
| HHM Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,536−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| HAP Trading, LLC | – | – | – | – | Not filed |